Molecules 2025 30(24):4802. doi: 10.3390/molecules30244802. Exploring EGFR, Nectin-4, and TROP-2 as Therapeutic Targets for Bladder Cancer Photoimmunotherapy Isis Wolf, Nora Giess, Céline Roider, Susanne Schultze-Seemann, Jonas Storz, Daniel B Werz, Arkadiusz Miernik, Christian Gratzke, Philipp Wolf
FEBS Open Bio 2025 doi: 10.1002/2211-5463.70179. Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer Sophie Leypold, Janik Riese, Lancelot Seillier, Mark Kühnel, Julia Pannhausen, Charlotte O J Fröhlich, Christian Martin, Peter Boor, Matthias Saar, Danny D Jonigk, Nadine T Gaisa, Michael Rose
J Exp Clin Cancer Res 2025 doi: 10.1186/s13046-025-03603-4. Targeting ATR offers multifaceted treatment strategies involving RAD51-mediated compensatory DNA repair in bladder cancer Julia Pannhausen, Ahmed A Chughtai, Cem-Louis Yüce, Michael K Melzer, Yanchun Ma, Lancelot Seillier, Emiel P C van der Vorst, Geoffroy Andrieux, Julia Wirtz, Sophie Leypold, Mark P Kühnel, Per Hoffmann, Stefanie Heilmann-Heimbach, Melanie Boerries, Alexander Kleger, Matthias Saar, Michael J Eble, Danny D Jonigk, Nadine T Gaisa, Michael Rose
Pathologie (Heidelb)2025 doi: 10.1007/s00292-025-01518-7. Evaluation of single-nucleotide variants in bladder cancer using prediction algorithms June Möller, Lancelot Seillier, Axel Fürstberger, Michael Rose, Danny D Jonigk, Nadina Ortiz-Brüchle, Nadine T Gaisa
Front Oncol 2025 15:1688779. doi: 10.3389/fonc.2025.1688779. Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort Maximilian Glienke, Ruth Himmelsbach, Max Zirngibl, Patrick Metzger, Julia Kühn, Cornelius Miething, August Sigle, Christian Gratzke, Cathleen Nientiedt, Michael Rassner, Heiko Becker, Justus Duyster, Silke Lassmann, Martin Werner, Melanie Börries, Markus Grabbert
Pathologie (Heidelb) 2025 doi: 10.1007/s00292-025-01507-w. POLQ and DNA-PK inhibition in muscle-invasive bladder cancer : Enhancing radiosensitivity with novel DNA damage response inhibitors to improve radiotherapy outcomes Julia Pannhausen, Ahmed A Chughtai, Michael K Melzer, Yanchun Ma, Julia Wirtz, Alexander Kleger, Matthias Saar, Michael J Eble, Danny D Jonigk, Michael Rose, Nadine T Gaisa
Sci Rep 2025 15(1):13443. doi: 10.1038/s41598-025-96419-3. Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer Julia Pannhausen, Julia Wirtz, Klaus Mantwill, Per-Sonne Holm, Kristina Schwamborn, Danny D Jonigk, Jürgen E Gschwend, Michael Rose, Nadine T Gaisa, Roman Nawroth
Commun Biol 2025 8(1):244. doi: 10.1038/s42003-025-07695-8. KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells Marvin Müller, Kyra Zodel, Behnaz A Abhari, Francesca Cuomo, Sheikh Nizamuddin, Patrick Metzger, Melanie Boerries, H T Marc Timmers, Ian J Frew
Nat Commun 2025 16(1):1191. doi: 10.1038/s41467-025-56492-8. Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth Yanhan Jia, Sheng Wang, Sylvia Urban, Judith M Müller, Manuela Sum, Qing Wang, Helena Bauer, Uwe Schulte, Heike Rampelt, Nikolaus Pfanner, Katrin M Schüle, Axel Imhof, Ignasi Forné, Christopher Berlin, August Sigle, Christian Gratzke, Holger Greschik, Eric Metzger, Roland Schüle
Kidney Int 2024 (24)00912-8. doi: 10.1016/j.kint.2024.12.003. Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma Antonella Catalano, Laura S Haas, Kyra Zodel, Mojca Adlesic, Francesca Cuomo, Asin Peighambari, Patrick Metzger, Hsin Huang, Stefan Haug, Anna Köttgen, Natalie Köhler, Melanie Boerries, Ian J Frew
Exp Hematol Oncol 2024 13(1):112. doi: 10.1186/s40164-024-00579-3. Prospective pharmacotyping of urothelial carcinoma organoids for drug sensitivity prediction – feasibility and real world experience Michael Karl Melzer, Yanchun Ma, Jessica Lindenmayer, Clara Morgenstern, Felix Wezel, Friedemann Zengerling, Cagatay Günes, Nadine Therese Gaisa, Alexander Kleger, Christian Bolenz
Mol Oncol 2024 18(6):1397-1416. doi: 10.1002/1878-0261.13623 Dual role of GRHL3 in bladder carcinogenesis depending on histological subtypes Franziska C Lammert, Julia Pannhausen, Erik Noetzel, Florian Friedland, Julia Wirtz, Yannick Herfs, Sophie Leypold, Lin Gan, Ralf Weiskirchen, Tician Schnitzler, Ruth Knüchel, Jochen Maurer, Danny D Jonigk, Michael Rose, Nadine T Gaisa
Cancers (Basel) 2024 Apr;16(8):1532. doi: 10.3390/cancers16081532. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer Sainab Totonji, Anna Ramos-Triguero, Dominica Willmann, Manuela Sum, Sylvia Urban, Helena Bauer, Astrid Rieder, Sheng Wang, Holger Greschik, Eric Metzger, Roland Schüle
Nat Rev Urol 2020 (12):655-656. doi: 10.1038/s41585-020-00386-5. The complex genetics of epigenetics in urothelial carcinomas Ian J Frew, H T Marc Timmers, Roland Schüle, Christian Gratzke
